Filing Details

Accession Number:
0001209191-19-047058
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-21 19:40:41
Reporting Period:
2019-08-19
Accepted Time:
2019-08-21 19:40:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1131324 Genomic Health Inc GHDX Services-Medical Laboratories (8071) 770552594
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1649167 Frederic Pla 301 Penobscot Dr.
Redwood City CA 94063
Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-19 1,251 $27.48 33,142 No 4 M Direct
Common Stock Disposition 2019-08-19 1,251 $75.00 31,891 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Holding Disposition 2019-08-19 1,251 $0.00 1,251 $27.48
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
42,402 2027-01-31 No 4 M Direct
Footnotes
  1. Includes an aggregate of 13,381 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
  2. These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018.
  3. Represents actual sale price.
  4. The option became exercisable as to 25% of the shares on January 31, 2018, and becomes exercisable as to 1/48th of the shares each full month thereafter.